The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine

The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine

BackgroundBrain metastases (BM) represent the most frequent intracranial tumors with increasing incidence. Many primary tumors are currently treated in protocols that incorporate targeted therapies either upfront or for progressive metastatic disease. Hence, molecular markers are gaining increasing...

Full description

Bibliographic Details
Main Authors: Sophie Katzendobler, Anna Do, Jonathan Weller, Kai Rejeski, Mario M. Dorostkar, Nathalie L. Albert, Robert Forbrig, Maximilian Niyazi, Rupert Egensperger, Joerg-Christian Tonn, Louisa von Baumgarten, Stefanie Quach, Niklas Thon
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
stereotactic biopsy
brain metastases
recurrent brain metastases
pseudoprogression
precision medicine
molecular diagnostics
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1014711/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1014711/full

Similar Items